MRI-based technologies for assessing non-alcoholic fatty liver disease
This guidance replaces the NICE medtech innovation briefing on LiverMultiScan for liver disease (MIB181).
Your responsibility
This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expecte...